Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a significant update in the clinical trial study involving Pembrolizumab for metastatic anal cancer treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:41:01.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing examples such as general health condition or prior treatments. Additionally, detailed eligibility criteria for participants with metastatic anal cancer have been specified.
    Difference
    50%
    Check dated 2024-05-22T21:08:56.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:34:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.